| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/31/2004 | EP1401495A2 T cell induced tissue repair and regeneration |
| 03/31/2004 | EP1401493A1 Subunit vaccines and processes for the production thereof |
| 03/31/2004 | EP1401490A1 Tsg101 as inhibitor of hiv production |
| 03/31/2004 | EP1401487A2 Method for induction of genome instability |
| 03/31/2004 | EP1401480A2 Use of endostatin in the treatment of ocular neovascularization |
| 03/31/2004 | EP1401475A2 Prmts as modifiers of the p53 pathway and methods of use |
| 03/31/2004 | EP1401472A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 03/31/2004 | EP1401470A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 03/31/2004 | EP1401469A2 Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways |
| 03/31/2004 | EP1401468A2 Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases |
| 03/31/2004 | EP1401456A1 Method fron determining the efficacy of reverse cholesterol transport enhancing agents |
| 03/31/2004 | EP1401429A2 Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis |
| 03/31/2004 | EP1401377A2 Methods for treating cancer |
| 03/31/2004 | EP1401376A2 Colloidal metal compositions and methods |
| 03/31/2004 | EP1401375A2 Methods for inhibiting macrophage colony stimulating factor and c-fms-dependent cell signaling |
| 03/31/2004 | EP1401281A2 Toll/interleukin-1 receptor adaptor protein (tirap) |
| 03/31/2004 | EP1401276A2 Implantation of biological pacemaker that is molecularly determined |
| 03/31/2004 | EP1401269A2 Transgenic animal model of bone mass modulation |
| 03/31/2004 | EP1401260A2 A method for altering the isoflavonoid profile in the plant parts of an isoflavonoid-producing plant |
| 03/31/2004 | EP1401259A2 Delta-4 desaturase genes and uses thereof |
| 03/31/2004 | EP1366059A4 Methods and compositions for modulating gluconeogenesis using pgc-1 |
| 03/31/2004 | EP1250156A4 Method for nucleic acid transfection of cells |
| 03/31/2004 | EP1234018B1 Method for porating biological membranes |
| 03/31/2004 | EP1232174A4 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 03/31/2004 | EP1230341A4 Geranyl diphosphate synthase large subunit, and methods of use |
| 03/31/2004 | EP1230338A4 Continuous-flow method for preparing microparticles |
| 03/31/2004 | EP1220950B1 Genetic markers of toxicity, preparation and uses thereof |
| 03/31/2004 | EP1181318B1 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 03/31/2004 | EP1169476A4 Detection of melanoma |
| 03/31/2004 | EP1158850A4 Plants and feed baits for controlling damage from feeding insects |
| 03/31/2004 | EP1108043B1 Method for non-homologous transformation of yarrowia lipolytica |
| 03/31/2004 | EP1019507B1 Amino-terminally truncated rantes as chemokine antagonists |
| 03/31/2004 | EP1019453B1 Aromatic-substituted xanthene dyes |
| 03/31/2004 | EP1015560B1 Modified small rna viruses |
| 03/31/2004 | EP1012256B1 Recombinant fusion proteins based on ribosome-inactivating proteins of european mistletoe viscum album |
| 03/31/2004 | EP1003863B1 Mammalian cytokine receptor-11 |
| 03/31/2004 | EP0975655A4 Improvements in adaptor-based sequence analysis |
| 03/31/2004 | EP0973887B1 Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof |
| 03/31/2004 | EP0935652B1 Keratinocyte growth factor-2 products |
| 03/31/2004 | EP0873411B1 Improved mutants of (2,5-dkg) reductase a |
| 03/31/2004 | EP0871758B1 Liposomal transfection method |
| 03/31/2004 | EP0866860B1 Novel tyrosine kinase receptors and ligands |
| 03/31/2004 | EP0852011B1 ANTIBODIES SPECIFIC FOR NATIVE PrP?Sc |
| 03/31/2004 | EP0784677B1 Inhibitor of stem cell proliferation and uses thereof |
| 03/31/2004 | EP0746625B1 Targetable vector particles |
| 03/31/2004 | EP0742833B1 Recombinant baculovirus and use thereof in the production of monoclonal antibodies |
| 03/31/2004 | EP0735818B1 MACROPHAGE INFLAMMATORY PROTEINS MIP-3, MIP-4 AND MIP-1gamma |
| 03/31/2004 | EP0731806B1 SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF |
| 03/31/2004 | EP0710253B1 Antibodies specific for human prostate glandular kallikrein |
| 03/31/2004 | EP0681477B1 Genetic modification of neural stem cells |
| 03/31/2004 | EP0666916B1 Plasmodium falciparum antigens inducing protective antibodies |
| 03/31/2004 | EP0656948B1 Bordetella bronchiseptica vaccine |
| 03/31/2004 | CN1486369A Method for separating and identifying flower pesticide specific promoter of cotton |
| 03/31/2004 | CN1486368A Methods for the production of multimeric proteins, and related compositions |
| 03/31/2004 | CN1486366A Methods and materials for the synthesis of organic products |
| 03/31/2004 | CN1486365A Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 03/31/2004 | CN1486328A Method for surface display of proteins on genetic carriers |
| 03/31/2004 | CN1486327A 载脂蛋白类似物 Apolipoprotein analogues |
| 03/31/2004 | CN1486192A Binding domain-immunoglobulin fusion proteins |
| 03/31/2004 | CN1485432A Exhibiting method of preparing antibody by antigen utilizing bacteriophage exhibiting technique |
| 03/31/2004 | CN1485431A Gene engineering yeast strain of expressing ª‰-1ú¼3-1ú¼4-glucanase |
| 03/31/2004 | CN1485430A Syncretic insecticidal protein gene having two insecticidal mechanism and application thereof |
| 03/31/2004 | CN1485427A Polypeptide-human proteolytic enzyme 70 and polynucleotide encoding the polypeptide |
| 03/31/2004 | CN1485426A Novel externally tangentú¡ª‰ú¡1ú¼4ú¡glucanase/internally tangentú¡ª‰ú¡1ú¼4ú¡xylanase and application thereof |
| 03/31/2004 | CN1485425A Cotton chitinase and encoding gene and application thereof |
| 03/31/2004 | CN1485424A Polypeptide-human acetyl galactosyltransferase 45 and polynucleotide encoding the polypeptide |
| 03/31/2004 | CN1485423A Polypeptide-human galactosyltransferase 42 and polynucleotide encoding the polypeptide |
| 03/31/2004 | CN1485341A Method for modifying growth factors by recombined technology |
| 03/31/2004 | CN1485340A Polypeptide-human transmembrane glycopeptide 25 and polynucleotide for encoding such polypeptide |
| 03/31/2004 | CN1485339A Polypeptide-human zinc finger protein 70 and polynucleotide for coding this polypeptide |
| 03/31/2004 | CN1485338A Polypeptide -Human vacuole carrier protein 13 and polynucleotide for encoding this polypeptide |
| 03/31/2004 | CN1485337A Polypeptide-human actin heavy chain 74 and polynucleotide for coding this polypeptide |
| 03/31/2004 | CN1485336A Polypeptide- human clathrin 82 and polynucleotide for coding such polypeptide |
| 03/31/2004 | CN1485335A Polypeptide-embryonic development protien 65 and polynucleotide for coding this polypeptide |
| 03/31/2004 | CN1485334A Polypeptide-human I complement receptor protein 222 and polynucleotide for coding such polypeptide |
| 03/31/2004 | CN1485333A Polypeptide-human X linked gene espression protein 14 and polynucleotide for encoding such polypeptide |
| 03/31/2004 | CN1485332A Polypeptide-human ª‰transducin 72 and polynucleotide for coding the same |
| 03/31/2004 | CN1143895C Gene engineering process for preparing diad/triad fusion protein of erythrocyte growth factor with improved bioactivity |
| 03/31/2004 | CN1143894C Human originating promoter for human body cell to express exogenous gene efficiently |
| 03/31/2004 | CN1143892C Recombinant sendal virus |
| 03/30/2004 | US6714923 Method for encrypting and decrypting information using rule-based templates embedded with synthetic gene sequences |
| 03/30/2004 | US6713666 Invertase inhibitors and methods of use |
| 03/30/2004 | US6713665 Nucleotide sequences coding polypeptide for use in generating disease resistant plants |
| 03/30/2004 | US6713664 Fatty acid elongase 3-ketoacyl CoA synthase polypeptides |
| 03/30/2004 | US6713663 Flowering locus T (FT) and genetically modified plants having delayed flower development |
| 03/30/2004 | US6713662 Production of collagen in the milk of transgenic mammals |
| 03/30/2004 | US6713633 Compounds capable of cleaving double-stranded DNA and method of utilization of the same |
| 03/30/2004 | US6713621 Chimeric compositions having multi-modalities are also provided which can affect a plurality of gene functions by interfering with splicing or translation as well as transcription |
| 03/30/2004 | US6713618 DNA which encodes trehalase and uses thereof |
| 03/30/2004 | US6713616 Detecting binding |
| 03/30/2004 | US6713611 Removing endotoxin from a basic protein; obtain solution containing basic protein, expose to detergent, expose to column, wash, elute basic protein from column |
| 03/30/2004 | US6713610 Human antibodies derived from immunized xenomice |
| 03/30/2004 | US6713607 Effector proteins of Rapamycin |
| 03/30/2004 | US6713606 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 03/30/2004 | US6713457 Strategy for suppressing the expression of an endogeneous gene by using compounds that are able to bind to the non-coding regions of the gene to be suppressed |
| 03/30/2004 | US6713456 Nucleozymes |
| 03/30/2004 | US6713453 Sustained release; drug delivery; tissue adhesive |
| 03/30/2004 | US6713451 Insulin-like growth factor agonist molecules |
| 03/30/2004 | US6713309 Arrays are constructed by sectioning bundles of tubules or rods containing unique reactants to produce large numbers of identical arrays |
| 03/30/2004 | US6713299 Separation column connected in flow communication with a reservoir having a collection chamber adapted for collection of filtrate or eluate |